The effects of solids retention time in full-scale activated sludge basins on trace organic contaminant concentrations.

Although pharmaceuticals and personal care products (PPCPs) and endocrine disrupting compounds (EDCs) are largely unregulated, water resource recovery facilities are increasingly using advanced chemical/physical treatment technologies (e.g., advanced oxidation and reverse osmosis) to remove or destroy these trace organic contaminants (TOrCs). This can both reduce potential adverse human health effects in reuse applications and mitigate environmental effects on aquatic ecosystems. Unfortunately, advanced treatment technologies are typically energy intensive and costly to implement, operate, and maintain. The goal of this study was to determine whether optimization of solids retention time (SRT) provided sufficient benefits to warrant such operational strategies for TOrC mitigation. Specifically, SRTs of 5.5, 6, and 15 days were evaluated to determine the effects on several standard wastewater parameters (e.g., nitrite, nitrate, and ammonia concentrations) and the degradation of TOrCs. The experimental SRTs were operated simultaneously in parallel, full-scale activated sludge basins. The results indicate that it can be beneficial to implement biological process optimization strategies using existing infrastructure while reducing reliance on advanced treatment technologies. This study also identified potential operational issues that might arise in activated sludge systems operating at extended SRTs.

Assessment of sample preservation techniques for pharmaceuticals, personal care products, and steroids in surface and drinking water.

Proper collection and preservation techniques are necessary to ensure sample integrity and maintain the stability of analytes until analysis. Data from improperly collected and preserved samples could lead to faulty conclusions and misinterpretation of the occurrence and fate of the compounds being studied. Because contaminants of emerging concern, such as pharmaceuticals and personal care products (PPCPs) and steroids, generally occur in surface and drinking water at ng/L levels, these compounds in particular require such protocols to accurately assess their concentrations. In this study, sample bottle types, residual oxidant quenching agents, preservation agents, and hold times were assessed for 21 PPCPs and steroids in surface water and finished drinking water. Amber glass bottles were found to have the least effect on target analyte concentrations, while high-density polyethylene bottles had the most impact. Ascorbic acid, sodium thiosulfate, and sodium sulfite were determined to be acceptable quenching agents and preservation with sodium azide at 4 °C led to the stability of the most target compounds. A combination of amber glass bottles, ascorbic acid, and sodium azide preserved analyte concentrations for 28 days in the tested matrices when held at 4 °C. Samples without a preservation agent were determined to be stable for all but two of the analytes when stored in amber glass bottles at 4 °C for 72 h. Results suggest that if improper protocols are utilized, reported concentrations of target PPCPs and steroids may be inaccurate.

Broad range analysis of endocrine disruptors and pharmaceuticals using gas chromatography and liquid chromatography tandem mass spectrometry.

Endocrine disrupting compounds (EDCs) and pharmaceuticals and personal care products (PPCPs) have been globally detected in impacted natural waters. The detection of trace quantities of EDCs and PPCPs in the environment is of great concern since some of these compounds have known physiological responses at low concentrations. EDCs can have a wide range of polarities, acidic and basic moieties, and exist in trace quantities, which often requires numerous complex extractions, large sample collection volumes, and multiple instrumental analyses. A comprehensive method has been developed allowing for the analysis of 58 potential EDCs in various water matrices using a single solid-phase extraction (SPE) of a 1L sample with subsequent analyses using both gas chromatography and liquid chromatography, each coupled with tandem mass spectrometry (GC-MS/MS and LC-MS/MS). Instrument detection limits ranged between 0.12-7.5 pg with corresponding method reporting limits of 1-10 ng l(-1) in water. Recoveries for most compounds were between 50% and 112% with good reproducibility (RSD 6-22%).

Treatment of poly- and perfluoroalkyl substances in U.S. full-scale water treatment systems.

The near ubiquitous presence of poly- and perfluoroalkyl substances (PFASs) in humans has raised concerns about potential human health effects from these chemicals, some of which are both extremely persistent and bioaccumulative. Because some of these chemicals are highly water soluble, one major pathway for human exposure is the consumption of contaminated drinking water. This study measured concentrations of PFASs in 18 raw drinking water sources and 2 treated wastewater effluents and evaluated 15 full-scale treatment systems for the attenuation of PFASs in water treatment utilities throughout the U.S. A liquid-chromatography tandem mass-spectrometry method was used to enable measurement of a suite of 23 PFASs, including perfluorocarboxylic acids (PFCAs) and perfluorosulfonic acids (PFSAs). Despite the differences in reporting levels, the PFASs that were detected in >70% of the source water samples (n = 39) included PFSAs, perfluorobutane sulfonic acid (74%), perfluorohexane sulfonic acid (79%), and perfluorooctane sulfonic acid (84%), and PFCAs, perfluoropentanoic acid (74%), perfluorohexanoic acid (79%), perfluoroheptanoic acid (74%), and perfluorooctanoic acid (74%). More importantly, water treatment techniques such as ferric or alum coagulation, granular/micro-/ultra- filtration, aeration, oxidation (i.e., permanganate, ultraviolet/hydrogen peroxide), and disinfection (i.e., ozonation, chlorine dioxide, chlorination, and chloramination) were mostly ineffective in removing PFASs. However, anion exchange and granular activated carbon treatment preferably removed longer-chain PFASs and the PFSAs compared to the PFCAs, and reverse osmosis demonstrated significant removal for all the PFASs, including the smallest PFAS, perfluorobutanoic acid.

Pilot-scale evaluation of ozone and biological activated carbon for trace organic contaminant mitigation and disinfection.

In an effort to validate the use of ozone for contaminant oxidation and disinfection in water reclamation, extensive pilot testing was performed with ozone/H(2)O(2) and biological activated carbon (BAC) at the Reno-Stead Water Reclamation Facility in Reno, Nevada. Three sets of samples were collected over a five-month period of continuous operation, and these samples were analyzed for a suite of trace organic contaminants (TOrCs), total estrogenicity, and several microbial surrogates, including the bacteriophage MS2, total and fecal coliforms, and Bacillus spores. Based on the high degree of microbial inactivation and contaminant destruction, this treatment train appears to be a viable alternative to the standard indirect potable reuse (IPR) configuration (i.e., membrane filtration, reverse osmosis, UV/H(2)O(2), and aquifer injection), particularly for inland applications where brine disposal is an issue. Several issues, including regrowth of coliform bacteria in the BAC process, must be addressed prior to full-scale implementation.

Pharmaceuticals and endocrine disrupting compounds in U.S. drinking water.

The drinking water for more than 28 million people was screened for a diverse group of pharmaceuticals, potential endocrine disrupting compounds (EDCs), and other unregulated organic contaminants. Source water, finished drinking water, and distribution system (tap) water from 19 U.S. water utilities was analyzed for 51 compounds between 2006 and 2007. The 11 most frequently detected compounds were atenolol, atrazine, carbamazepine, estrone, gemfibrozil, meprobamate, naproxen, phenytoin, sulfamethoxazole, TCEP, and trimethoprim. Median concentrations of these compounds were less than 10 ng/L, except for sulfamethoxazole in source water (12 ng/L), TCEP in source water (120 ng/L), and atrazine in source, finished, and distribution system water (32, 49, and 49 ng/L). Atrazine was detected in source waters far removed from agricultural application where wastewater was the only known source of organic contaminants. The occurrence of compounds in finished drinking water was controlled by the type of chemical oxidation (ozone or chlorine) used at each plant. At one drinking water treatment plant, summed monthly concentrations of the detected analytes in source and finished water are reported. Atenolol, atrazine, DEET, estrone, meprobamate, and trimethoprim can serve as indicator compounds representing potential contamination from other pharmaceuticals and EDCs and can gauge the efficacy of treatment processes.

Perchlorate and chlorate in dietary supplements and flavor enhancing ingredients.

The oxyhalide anions perchlorate and chlorate were measured in a series of dietary (vitamin and mineral) supplements and flavor enhancing ingredients collected from various commercial vendors in two large US cities. Analyses were conducted using liquid chromatography with tandem mass spectrometry (LC-MS/MS). The limit of detection was based on the mass of supplements and ingredients extracted and ranged from 2 to 15 ng/g for perchlorate and 4 to 30 ng/g for chlorate. Perchlorate and chlorate were detected in 20 and 26, respectively, of the 31 dietary supplements tested, with concentrations ranging from non-detectable to as high as 2400 and 10,300 ng/g, respectively. Based upon the recommended dose provided by each manufacturer for different supplements, the daily oral dose of perchlorate and chlorate could be as high as 18 and 20 microg/day, respectively. The highest level of perchlorate was found in a supplement recommended for pregnant women as a prenatal nutritional supplement. Of the 31 dietary supplements investigated, 12 were specifically marketed for pregnant women and children. Perchlorate and chlorate were also detectable in four products marketed for the enhancement of food flavor. Perchlorate is found naturally in some parts of the world, is present in some natural fertilizers, is used as an oxidizer in solid fuel engines, and has been used at therapeutic doses in humans to treat overactive thyroid glands. Perchlorate has been detected in drinking water, dairy products, some produce and grains, and human breast milk. This is the first report of perchlorate measured in over-the-counter dietary supplements and flavor enhancing ingredients.